Cost-related Medication Behaviors for Patients with and without Systemic Autoimmune Rheumatic Diseases

Autoimmune Disease

Opioid Use for Adults with and without Systemic Autoimmune/Inflammatory Rheumatic Diseases: Analysis of 2006-2019 United States National Data

Arthritis Care Res (Hoboken)

Huang Y, Bruera S, Agarwal SK, Suarez-Almazor ME, Bazzazzadehgan S, Ramachandran S, Bhattacharya K, Bentley JP, Yang Y

doi: 10.1002/acr.25378

Further Publications Rheumatology

Risk factors of COVID-19 related hospitalization of pediatric patients with rheumatic diseases: a systematic review and meta-analysis

Rheumatology (Oxford)

Zhao Q, Wallace B, Ronis T, Jung L

doi: 10.1093/rheumatology/keae664

Autoimmune DiseaseFurther Publications Rheumatology

Identifying key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases: a mixed-methods study

Lancet Rheumatol

Hollick RJ, James WRG, Nicoll A, Locock L, Black C, Dhaun N, Egan AC, Fluck N, Laidlaw L, Lanyon PC, Little MA, Luqmani RA, Moir L, McBain M, Basu N

doi: 10.1016/S2665-9913(24)00082-1

Autoimmune DiseaseFurther Publications ImmunologyFurther Publications Rheumatology

Prevalence and Risk Factors of Post-Acute Sequela of COVID-19 in Adults with Systemic Autoimmune Rheumatic Diseases

J Rheumatol

Teles MS, Brundage J, Chiang TP, Alejo JL, Henriquez N, Wallwork R, Christopher Stine L, Massie A, Segev DL, Connolly CM, Paik JJ, Werbel WA

doi: 10.3899/jrheum.2023-1212

Rheumatoid Arthritis

Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis - a nested case-control study within the German biologics register RABBIT

Arthritis Res Ther

Ramien R, Rudi T, Alten R, Krause A, Schneider M, Schaefer M, Strangfeld A, Meissner Y

doi: 10.1186/s13075-024-03449-9

Systemic Sclerosis

Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study

J Autoimmun

Chaigne B, Bense A, Aubourg F, Agard C, Allanore Y, Berezne A, Pugnet G, Hachulla E, Cottin V, Hot A, Dunogue B, Kanagaratnam A, Palat S, Lescoat A, Berthier S, Chatelus E, Rivière S, Launay D, Truchetet ME, Dinh-Xuan AT, Mouthon L, French Systemic Sclerosis Network

doi: 10.1016/j.jaut.2025.103391

Autoimmune Disease

Janus Kinase Inhibitor Therapy and Risk of Age-Related Macular Degeneration in Autoimmune Disease

JAMA Ophthalmol

Hallak JA, Abbasi A, Goldberg RA, Modi Y, Zhao C, Jing Y, Chen N, Mercer D, Sahu S, Alobaidi A, López FJ, Luhrs K, Waring JF, den Hollander AI, Smaoui N

doi: 10.1001/jamaophthalmol.2024.2376

Further Publications Rheumatology

Risk of gastrointestinal perforation in patients with rheumatic diseases exposed to janus kinase inhibitors versus adalimumab: nationwide cohort study

Arthritis Rheumatol

Hoisnard L, Meyer A, Dray-Spira R, Weill A, Zureik M, Sbidian E

doi: 10.1002/art.42862

Rheumatoid Arthritis

Trends in avascular necrosis and related arthroplasties in hospitalized patients with systemic lupus erythematosus and rheumatoid arthritis

Semin Arthritis Rheum

Dhital R, Singh NC, Spiker AM, Poudel DR, Pedersen B, Bartels CM

doi: 10.1016/j.semarthrit.2024.152444

Related content